decursin and Sarcoma-180

decursin has been researched along with Sarcoma-180* in 1 studies

Other Studies

1 other study(ies) available for decursin and Sarcoma-180

ArticleYear
Anti-tumor activities of decursinol angelate and decursin from Angelica gigas.
    Archives of pharmacal research, 2003, Volume: 26, Issue:9

    The in vivo anti-tumor activities of decursinol angelate (1) and decursin (2) isolated from the roots of Angelica gigas were investigated. These two compounds, when administered consecutively for 9 days at 50 and 100 mg/kg i.p. in mice, caused a significant increase in the life span and a significant decrease in the tumor weight and volume of mice inoculated with Sarcoma-180 tumor cells. These results suggest that decursinol angelate (1) and decursin (2) from A. gigas have anti-tumor activities.

    Topics: Angelica; Animals; Antineoplastic Agents, Phytogenic; Benzopyrans; Butyrates; Cell Line, Tumor; Fluorouracil; Injections, Intraperitoneal; Korea; Male; Medicine, East Asian Traditional; Mice; Mice, Inbred ICR; Neoplasm Transplantation; Neoplasms; Plant Extracts; Plant Roots; Sarcoma 180; Survival Rate

2003